Finast 5mg (Finasteride)

Product Overview

Finast 5mg is a pharmaceutical tablet manufactured by Dr Reddy’s Laboratories Ltd. Each strip contains 30 film‑coated tablets that deliver a precise 5 mg dose of finasteride, a synthetic 4‑azasteroid compound. The product is formulated for oral administration and is intended for the management of benign prostatic hyperplasia (BPH) in adult men. Pack options include 30, 60, or 90 tablets, allowing patients to select a supply that matches their treatment duration. Shipping typically occurs within six to fifteen days after order confirmation, depending on the destination and customs processing.

What is Finast 5mg (Finasteride)

Finasteride belongs to the class of 5‑alpha‑reductase inhibitors. It works by reducing the conversion of testosterone into dihydrotestosterone (DHT), a hormone that stimulates prostate growth. The active ingredient is chemically designated as N‑[2,3‑bis(trifluoromethyl)phenyl]-3‑oxa‑5‑azasteroid. Although the original clinical studies focused on male patients with BPH, the same mechanism has been explored in off‑label infertility protocols for women, particularly in cases of androgen‑dependent ovarian dysfunction. However, the U.S. Food and Drug Administration (FDA) has not approved finasteride for female infertility, and its use in this population should be guided by a qualified healthcare professional.

Uses and Benefits

The primary therapeutic indication for Finast 5mg is the reduction of symptomatic complaints associated with BPH, such as urinary frequency, urgency, weak stream, and nocturia. Clinical trials have demonstrated that a daily 5 mg dose can shrink prostate volume by up to 20 % after six months of treatment, leading to improved urinary flow rates and a lower need for surgical intervention. In addition, some physicians prescribe finasteride off‑label for male pattern alopecia and for certain ovulatory disorders in women, citing its ability to modulate androgenic pathways. Patients often report a gradual alleviation of lower‑urinary‑tract symptoms, which can enhance quality of life and reduce the frequency of hospital visits.

How It Works

Finasteride inhibits the enzyme 5‑alpha‑reductase type II, which catalyzes the conversion of testosterone to DHT. DHT is a more potent androgen that binds to androgen receptors in prostatic stromal and epithelial cells, promoting cellular proliferation. By decreasing DHT concentrations by approximately 70 % in the serum and prostatic tissue, finasteride slows the growth of the hyperplastic nodules and may reverse some of the existing enlargement. This pharmacodynamic effect is dose‑dependent; the 5 mg strength used for BPH achieves a greater enzymatic blockade than the 1 mg strength marketed for androgenic hair loss. The reduction in DHT levels also underlies the observed benefits in select infertility regimens, where lower androgen activity can improve follicular development.

Dosage Guidelines

The recommended adult dosage for the treatment of benign prostatic hyperplasia is one 5 mg tablet taken orally once daily, with or without food. Therapy is usually initiated under medical supervision, and patients should be monitored for clinical response after three to six months of treatment. If a dose is missed, the patient should take the next scheduled dose rather than double up, to maintain steady plasma concentrations. For patients with hepatic impairment, a lower dose may be considered, and renal‑adjusted dosing is not required because finasteride is primarily metabolized by the liver. It is essential to adhere to the prescribed schedule, as irregular dosing can diminish the therapeutic effect and increase the risk of adverse events.

Side Effects

Like all medications, finasteride can produce side effects, although many are mild and transient. The most frequently reported adverse reactions include decreased libido, erectile dysfunction, and ejaculatory disorders. Some users experience breast tenderness or enlargement, which typically resolves after discontinuation. Less common but clinically important effects include dizziness, headache, and allergic skin reactions such as rash or pruritus. Rarely, patients may experience mood alterations or a small increase in the risk of high‑grade prostate cancer; however, current evidence does not establish a causal relationship. Patients should be advised to report any persistent or severe symptoms to their physician promptly.

Warnings and Precautions

Finast 5mg is contraindicated in women who are pregnant or may become pregnant, as finasteride can be absorbed through the skin and may cause abnormalities in male fetal development. Men should avoid sharing the medication with female partners of child‑bearing age. Patients with severe hepatic disease should use the drug with caution, and regular liver function tests may be recommended during long‑term therapy. It is also advisable to inform the prescribing clinician of any concurrent medications, especially those that affect cytochrome P450 enzymes, to avoid potential drug interactions. Finally, patients scheduled for surgery involving the prostate should discuss the use of finasteride with their surgeon, as the drug can alter prostate size and affect operative planning.

Additional Information

For more detailed prescribing information, refer to the product’s official label or consult a licensed healthcare provider. The National Institutes of Health (NIH) provides comprehensive resources on prostate health at nih.gov. The U.S. Food and Drug Administration (FDA) offers up‑to‑date guidance on finasteride safety at fda.gov. Clinical studies indexed on PubMed can be accessed through pubmed.ncbi.nlm.nih.gov for readers interested in the underlying research. Delivery of Finast 5mg typically takes six to fifteen days, depending on the shipping method and customs clearance.

Frequently Asked Questions

Question 1: What is the difference between Finast 5mg and the 1 mg tablet used for hair loss?

Answer: Finast 5mg contains a higher dose of finasteride specifically approved for the treatment of benign prostatic hyperplasia. The 1 mg formulation is intended for male pattern hair loss and delivers a lower systemic exposure, resulting in a different therapeutic indication.

Question 2: Can women take Finast 5mg for infertility?

Answer: Finasteride is not FDA‑approved for female infertility. Its use in women is considered off‑label and should only be pursued under the supervision of a qualified physician who can assess the potential benefits and risks.

Question 3: How long does it take to notice improvement in urinary symptoms?

Answer: Most patients report a measurable reduction in symptoms after three to six months of consistent daily dosing. Individual response may vary based on baseline prostate size and severity of the condition.

Question 4: Is it safe to combine Finast with other prostate medications?

Answer: Combining finasteride with other agents such as alpha‑blockers can be part of a combined therapy regimen, but the decision should be made by a healthcare professional who can monitor for additive side effects.

Question 5: What should I do if I miss a dose?

Answer: If you forget to take a dose, simply take the next scheduled tablet at the usual time. Do not double the dose to make up for the missed one, as this can increase the likelihood of adverse effects.

Related Products

• Razo (Rabeprazole)
• Morease-I Granules (Mebeverine/Ispaghula)
• Razo 10 mg (Rabeprazole)
• Omeprazole 40 mg (Generic)
• Omez 10 mg (Omeprazole)
• Omez 20 mg (Omeprazole)
• Omez 40 mg (Omeprazole)
• Omez (Omeprazole)
• Razo 20 mg (Rabeprazole)
• Omeprazole 10 mg (Generic)
• Omeprazole 20 mg (Generic)
• Salicylix SF 6% Cream (Salicylic Acid)